Benjamin Cravatt III
From Wikipedia, the free encyclopedia
 |
|
| Born | |
|---|---|
| Field | Chemical Biology |
| Institution | The Scripps Research Institute ActivX Biosciences |
| Known for | Proteomics |
Benjamin F Cravatt is a professor in the Departments of Cell Biology and Chemistry at The Scripps Research Institute in La Jolla, California. Considered the inventor of activity based proteomics, he is a prominent figure in the nascent field of chemical biology. He has made contributions to the cannabinoid field, most notably, identification and characterization of the endocannabinoid-terminating enzyme fatty acid amide hydrolase, FAAH.
Cravatt is a Cope and Searle scholar, and the co-founder of ActivX Biosciences.
[edit] Related links
[edit] External links
 |
This article about an American businessperson is a stub. You can help Wikipedia by expanding it. |
